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Impact of Support Groups for People Living With HIV
on Clinical Outcomes: A Systematic
Review of the Literature
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Background: Support groups for people living with HIV are
integrated into HIV care and treatment programs as a modality for
increasing patient literacy and as an intervention to address the
psychosocial needs of patients. However, the impact of support
groups on key health outcomes has not been fully determined.
Methods: We searched electronic databases from January 1995
through May 2014 and reviewed relevant literature on the impact of
support groups on mortality, morbidity, retention in HIV care,
quality of life (QOL), and ongoing HIV transmission, as well as their
cost-effectiveness.
Results: Of 1809 citations identiﬁed, 20 met the inclusion
criteria. One reported on mortality, 7 on morbidity, 5 on retention
in care, 7 on QOL, and 7 on ongoing HIV transmission. Eighteen
(90%) of the articles reported largely positive results on the impact
of support group interventions on key outcomes. Support groups
were associated with reduced mortality and morbidity, increased
retention in care, and improved QOL. Because of study limi-
tations, the overall quality of evidence was rated as fair for
mortality, morbidity, retention in care, and QOL, and poor for
HIV transmission.
Conclusions: Implementing support groups as an intervention is
expected to have a high impact on morbidity and retention in care
and a moderate impact on mortality and QOL of people living with
HIV. Support groups improve disclosure with potential prevention
beneﬁts but the impact on ongoing transmission is uncertain. It is
unclear whether this intervention is cost-effective given the paucity
of studies in this area.
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INTRODUCTION
HIV programs use support groups as an opportunity for
health care workers to provide information to people living
with HIV (PLHIV). HIV posttest clubs were among the ﬁrst
support groups to be used to provide support to clients who
tested positive for HIV.1 The World Health Organization
(WHO) proposes support groups as an intervention to address
retention and adherence among PLHIV receiving antiretro-
viral therapy (ART).2
Both WHO and the US President’s Emergency Plan for
AIDS Relief (PEPFAR) promote peer support groups facilitated
by trained PLHIV to address the special needs of fellow PLHIV
and their partners.3,4 Such groups serve the purpose of sharing
experiences, encouraging disclosure, reducing stigma and
discrimination, improving self-esteem, enhancing patients’
coping skills and psychosocial functioning, and supporting
medication adherence and improved retention in HIV care.5–7
These beneﬁts can be maximized further if the support groups
are formed around speciﬁc populations such as men who have
sex with men, pregnant women, adolescents, or couples in
discordant relationships. Support groups are also considered an
intervention in the management of mental health issues,
including alcohol and other substance abuse disorders.2 Support
groups are generally initiated and supported by nongovernmen-
tal organizations, civil society, or community-based organiza-
tions and may convene in a health facility or in the community.
Disclosure of HIV-positive status, one of the potential
beneﬁts of support groups, has broad prevention implica-
tions and is emphasized by both the WHO and the Centers
for Disease Control and Prevention (CDC) in all HIV testing
protocols.8,9 The Mentor Mother support group model—
using mothers living with HIV—is a key strategy in the
United Nations Global Plan for elimination of pediatric
AIDS by 2015 and for keeping mothers alive.10 The Mentor
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Mothers is considered an effective intervention to improve
maternal and infant well-being among women living with
HIV. They work alongside health care workers in the clinic
and at community meetings to provide health education, to
promote adherence to ART, and to promote disclosure of
HIV status among other services.11
Although the WHO and PEPFAR promote the role of
support groups,2,4 evidence of their impact on key health
outcomes has not been assessed. This article presents the
results of a systematic review of studies examining the
evidence of impact of support groups on mortality, morbidity,
retention in care, quality of life (QOL), and HIV transmission,
and determining whether they are cost-effective.
METHODS
This review was conducted as part of an assessment of
13 care and support interventions funded by PEPFAR.12
Details about the interventions and methods for the review
including the general search strategy are described fully in the
introductory article of this supplement.13
The review team conducted a systematic search of the
literature using: Medline (through PubMed), EMBASE, Global
Health, CINAHL (Cumulative Index to Nursing and Allied
Health Literature), SOCA (Sociological Abstracts), and AIM
(African Index Medicus) from January 1995 through May
2014 using the following Medical Subject Headings (MeSH)
terms: HIV, community support, social support group, informal
group, PLHIV network, PLHIV group, volunteer group,
support group, self-help group, self-help, peer support and
peer support group. These were used in addition to the general
search terms described in the introductory article.13
The authors reviewed the citations and abstracts
independently and identiﬁed studies that seemed to address
support group interventions and at least 1 of the outcomes of
interest. For these “eligible” studies, full-text articles were
obtained and evaluated independently by 2 authors. Studies
that met the following criteria were “included” in the review:
(1) evaluated the impact of HIV support groups, (2) were
conducted in resource-limited settings, and (3) addressed 1 or
more of the outcomes of interest—mortality, morbidity,
retention in HIV care, QOL, or prevention of ongoing HIV
transmission. Costing and cost-effectiveness outcomes where
available were also considered.
The following data were abstracted from each study
that fulﬁlled the inclusion criteria: study characteristics
(citation, design, study year and year of publication), key
ﬁndings (the magnitude of effect of the intervention, pre-
sented as hazard ratios, odds ratios, or relative risk and 95%
conﬁdence intervals), and the quality of evidence. For the
latter, we assessed the internal and external validity and other
factors and rated the quality of evidence of each study as
strong, medium, or weak. Qualitative studies were rated on
a scale of I–IV based on methods adapted from Daly et al.14
The methods for rating study quality are described in detail in
the introductory article in this supplement.13
Variability in the intervention, study design, and study
population precluded combining study results or meta-analysis.
Instead, the review team summarised results from all studies
that reported on each outcome. We rated the overall quality of
evidence for each outcome as good, fair, or poor based on the
criteria developed a priori. We then rated the expected
impact —based on the magnitude of effect reported in
individual studies, the quality of the body of evidence (all
studies addressing each outcome), and consistency of results
across the studies—of the intervention on each outcome as
high, moderate, low, or uncertain (further details regarding
rating of quality of evidence for individual studies and quality
of evidence and expected impact for each outcome can be
found in the introductory article in this supplement).13
RESULTS
We screened 1809 abstracts and deemed 137 of the
studies to be eligible (Fig. 1). Full-text articles of these 137
studies were reviewed; 20 met the “inclusion” criteria. Studies
that were not “included” either did not address support groups as
an intervention or did not report on any of the outcomes of
interest. Characteristics of the 20 included studies are
presented in Table S1 (see Supplemental Digital Content,
http://links.lww.com/QAI/A645). Six articles reported on
multiple outcomes, whereas 14 addressed 1 outcome of
interest (see Table S1, Supplemental Digital Content,
http://links.lww.com/QAI/A645). The majority of studies
were conducted in sub-Saharan Africa: South Africa
(n = 7)16,18,22,31,32,35,37; Kenya (n = 2)17,29; Mozambique
(n = 2)15,23; and one each from Nigeria,21 Rwanda,19
Tanzania,20 Uganda,30 and Zimbabwe.25 Two studies were
conducted in Vietnam33,34; the remaining 2 reported multi-
country results.28,36
Most studies (18) were observational—using either
a cross-sectional or cohort design (11), a qualitative (5), or
a mixed methods study design (2); and 2 were experimental
studies—an unblinded randomized controlled study20 and
a study using a quasi-experimental design.32 Sample sizes
ranged from 21 in a qualitative study to over 300,000 in
a multicountry observational cohort. Three studies targeted only
women; 1 recruited only men; the remaining studies (n = 16)
included both men and women. In addition to being enrolled in
support groups, PLHIV often received other interventions, such
as being seen by community health workers or being assigned
treatment buddies. Table S1 (see Supplemental Digital Content,
http://links.lww.com/QAI/A645) presents further details on the
characteristics and ﬁndings from the 20 individual studies.
Outcomes, Quality of the Evidence and
Expected Impact
Mortality
One study examined the effect of support groups on
mortality. Decroo et al, reporting on a Mozambique cohort,
found a mortality rate among 5729 individuals enrolled in
Community Adherence Groups (CAGs) of only 2.1 per 100
person-years and a loss to follow-up (LTFU) rate of 0.1 per 100
person-years. Only 208 (3.6%) were reported as dead after
a median follow-up time of 19 months (interquartile range:
10–29).15 The authors also reported an overall attrition of 3.9%
mostly from mortality (3.7%) and the rest from LTFU (0.2%).
J Acquir Immune Defic Syndr  Volume 68, Supplement 3, April 15, 2015 Impact of Support Groups for PLHIV
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. www.jaids.com | S369
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.5
Factors associated with attrition (both mortality and LTFU) were
presented at individual and group level. At the individual level,
attrition in CAGs was associated with a low CD4 count at the
time of enrollment in CAG [aHR 2.28, 95% conﬁdence interval
(CI): 1.60 to 3.24] and being male (aHR 1.93, 95% CI: 1.48 to
2.51). At the group (CAG) level, lack of rotational representation
by each of the different group members at the clinic (aHR 1.72,
95% CI: 1.27 to 2.33), lack of regular CD4 count ascertainment
among members of the same group (aHR 1.88, 95% CI: 1.18 to
3.00), and attending a rural (aHR 2.59, 95% CI: 1.81 to 3.70) or
district clinic (aHR 1.57, 95% CI: 1.14 to 2.16) were associated
with higher attrition. There was no comparison group.
Reviewers rated the “overall” quality of evidence for
the outcome of mortality as fair. However, the expected
impact on mortality was rated as moderate based on the low
mortality rate among those who participated in the support
groups in this study (Table 1).
Morbidity
Seven studies16–22 reported on the impact of
support group interventions on a range of morbidity
outcomes (see Table S1, Supplemental Digital Content,
http://links.lww.com/QAI/A645). Support groups were
associated with reduced frequency of HIV-related symptoms—
somatic symptoms, anxiety and insomnia,18 and depression.20–22
Other beneﬁts included improved access to ART, adherence to
ART and treatment success,16,17,19,25 measured as time to
treatment failure and reduced risk of detectable viremia or
change in the CD4 cell count. For example, Achieng et al17
reported that time to treatment failure was longer in patients
participating in support groups (448 days vs. 337 days, P =
0.001). Results from a South African cohort of 268 PLHIV
enrolled in the public sector HIV treatment program reported
participation in a support group as a predictor of treatment
success (ie, viral load , 400 copies/mL, CD4 . 200 cells/mL),
during the ﬁrst 6, 12, and 24 months of ART.16 Support group
participants were signiﬁcantly more likely to have an undetect-
able viral load (P, 0.001) and a CD4 cell count. 200 cells per
milliliter at 12 months (P , 0.01) than those who did not
participate in a support group. Viral load suppression was
maintained beyond 24 months after enrollment in a support
group (P, 0.01). In the Muchedzi study, women tested for HIV
in a prevention of mother-to-child transmission (PMTCT) pro-
gram and enrolled in a support group were twice as likely to
access care and treatment (OR = 2.34, 95% CI: 1.13 to 4.88)
although their treatment outcomes were not reported.25 Outcomes
from the remaining 5 studies are presented in Table S1 (see
Supplemental Digital Content, http://links.lww.com/QAI/A645).
Although ﬁndings from the 7 studies consistently
reported morbidity beneﬁts, reviewers rated the overall
quality of evidence as fair based on limitations of the included
studies. Almost all were cross-sectional, qualitative, or had
small sample sizes. In addition, different morbidity-related
outcomes were reported. Nevertheless, the expected impact of
support groups on reducing morbidity in PLHIV was rated as
high based on signiﬁcant associations between support group
participation and decrease in morbidity from studies from 6
different countries.
Retention in Care
Five studies15,16,23,25,28—2 from the same Mozambique
cohort16,23—reported low LTFU for patients on ART partici-
pating in support groups. Decroo et al23 reported high
retention with approximately 97.5% patients remaining in
care for a median follow-up period of 12.9 months (range,
8.5–14 months) and 91.8% at 4 years.15 Overall, the authors
reported that attrition in the cohort was lower than the
national 12-month average for Mozambique (15%)38 and
even lower than rates reported in the literature for sub-
FIGURE 1. Total number of studies
identified, screened, eligible, and
included in the systematic review of
support groups for PLHIV January
1990–May 2014.
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Saharan Africa (1.2%–26%).24 A large study with more than
300,000 participants aged 10–24 years from 4 sub-Saharan
countries showed that youth participating in support groups
provided by clinics experienced slightly lower attrition after
ART initiation (AHR = 0.73, 95% CI: 0.52 to 1.0); in the pre-
ART period, the authors reported no signiﬁcant associations
between attrition and participation in support groups or other
adolescent friendly services—availability of adolescent peer
educators, or education on high-risk substance abusing
behaviour.28 Higher retention among support group partic-
ipants was also reported among patients on ART in South
Africa16 and among women enrolled in the PMTCT program
in Zimbabwe25 (see Table S1, Supplemental Digital Content,
http://links.lww.com/QAI/A645).
Reviewers categorized the quality of evidence for this
outcome as fair. All 5 studies were observational. Sample
sizes were small for 2 of the studies16,25 and the ﬁndings from
the larger study28 are not generalizable beyond the 10- to 24-
year age group. Lack of a comparison group in 2 studies15,23
and other methodological limitations affected the quality of
evidence for this outcome. The expected impact of support
groups on retention was rated as high for patients on ART but
uncertain for pre-ART patients (Table 1).
Quality of Life
Seven studies—5 qualitative,29–31,33,34 1 quasi-experimen-
tal,32 and the other using mixed methods18—reported associa-
tions between membership and/or attendance at support groups
and several measures of QOL (see Table S1, Supplemental
Digital Content, http://links.lww.com/QAI/A645). Measures
varied by study and included reported improvement in symp-
toms, improved conﬁdence and self-esteem, better coping skills,
and perceived reduction in stigma. The authors reported that
support group participation enabled patients to seek care30 and
start ARVs.34 Other beneﬁts reported by Kim et al30 were spill-
over effects to the community in which HIV-infected persons
who were not in support groups were encouraged to seek care.
Although the beneﬁts were mostly positive, Mfecane31 reported
that a cohort of men who attended support groups felt that
participation imposed pressure to conform in a way that
negatively affected their perception of masculinity. Dageid
and Duckert18 reported negative effects such as inadvertent
disclosure of HIV-positive status and gossip and stigmatization
from other support group members and/or the community.
Reviewers categorized the quality of evidence for this
outcome as poor. Four of the studies were qualitative29,30,33,34
and most had small sample sizes. One reported only on
men,31 and 3 only on women,29,32,33 limiting the generaliz-
ability of the ﬁndings. Despite the limitations in some of the
studies, the expected impact on QOL was rated as moderate
(Table 1) based on consistently positive results on QOL
across studies.
HIV Transmission
Seven studies20,27,29,30,35–37 reported on outcomes,
which may directly or indirectly impact HIV transmission,
TABLE 1. Summary of Evidence From All Studies by Outcome
Outcomes




















Mortality 115 Fair Moderate None NA Some support group characteristics
described in the South Africa settings
do provide some important lessons
Morbidity 716–22 Fair High None NA Almost all studies were cross-sectional or
qualitative and only demonstrate
associations. Different outcomes for




515,16,23,25,28 Fair High None NA Results from several large cohorts
demonstrate sustained retention
especially in ART patients
QOL 718,29–34 Poor Moderate None NA As reported, the studies all used different
measures of QOL. All reported
outcomes would have an impact on
QOL for PLHIV directly or indirectly
HIV
transmission
720,27,29,30,35–37 Poor Uncertain None NA Three of the 4 studies were conducted in
South Africa, with mixed results. One
study conducted elsewhere had mixed
results and involved nonrepresentative
sample of participants from each
country
Assessment of the expected impact of the intervention was based on published evidence. Additional considerations that would inform implementation decisions would have to take
into account the cost-effectiveness information and country speciﬁc contextual considerations.
*The expected impact of the intervention was rated as: high, intervention expected to have a high impact on the outcome; moderate, likely to have a moderate impact on the
outcome; low, intervention expected to have a low impact on the outcome; and uncertain, available information is not adequate to assess estimated impact on the outcome.
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such as risky sexual behavior and disclosure of HIV-positive
status to sex partners. Three of the 7 studies were conducted
in South Africa16,35,37 (see Table S1, Supplemental Digital
Content, http://links.lww.com/QAI/A645). Gaede et al35 re-
ported positive associations between attendance at support
groups and health behaviors and condom use. Four stud-
ies20,27,36,37 reported mixed results regarding the association
between support group participation and disclosure of HIV
status; Skogmar found no signiﬁcant difference in disclosure
rates between those who attended only pretest/posttest counsel-
ing (standard of care) and those who received either professional
counseling or participated in support groups.37 Woulters
reported that assistance of community health workers and
support group participation resulted in disclosure of HIV status
to non-family members only in the second year of implementa-
tion of the program; however, the impact of support groups
alone was not reported.27 Hardon et al,36 in a mixed methods
study involving participants from 4 African countries (Burkina
Faso, Kenya, Malawi, and Uganda), showed that membership in
a support group was associated with not disclosing to partners
for fear of stigma—the experience of prejudice and discrimina-
tion as the consequence of being HIV positive. Additionally,
although an unblinded randomized control study conducted in
Tanzania reported a 20% increase in disclosure for support
group participants compared with controls, the difference
was not statistically signiﬁcant (RR = 1.2, 95% CI: 0.91 to
1.6, P = 0.19) and 12% of those who gave feedback about the
disclosure reported negative reactions such as anger, blame, and
being told to leave the household.20 Two articles reported an
association between support group attendance and increased
disclosure to spouses and other family members.29,30
Reviewers categorized the quality of evidence from the
7 studies as poor and the expected impact on HIV trans-
mission as uncertain.
DISCUSSION
We identiﬁed 20 studies from low- and middle-income
countries, which evaluated the impact of support groups on
mortality, morbidity, retention in care, QOL, or HIV trans-
mission. No studies reported costing or cost-effectiveness
data. The studies were primarily from sub-Saharan Africa and
varied in study design, target population, and sample size.
The review found largely positive results. Although
limited by the quality of the included studies, the data suggest
potential beneﬁt of support groups on key health outcomes.
We rated the expected impact of support groups as an
intervention in PLHIV as high in terms of reducing morbidity
and improving retention in care. Support groups also have the
potential to inﬂuence mortality, QOL, and prevention of
ongoing HIV transmission. Speciﬁc positive beneﬁts associ-
ated with support group membership include enhancing
treatment success and improving the QOL through equipping
PLHIV with coping skills.
With the development of community-based care models
in some settings, support groups could provide an opportunity
for PLHIV to share experiences and become more engaged in
their care. Given the severe human resource challenges in
sub-Saharan Africa, speciﬁcally the shortage of trained health
care providers,26 support groups can play an increasingly
larger role in care models, particularly regarding retaining
HIV-infected persons in care. Based on success of the pilot
program developed by Médecins Sans Frontières (MSF) and
provincial health ofﬁcials in Mozambique reported in this
review,15,23 the Mozambique Ministry of Health is scaling up
CAGs nationally.
We did not speciﬁcally search for adherence as an
outcome in this review. However, 5 studies reported increased
adherence to ART16,17,19,31 associated with support group
participation. In the study by Wouters et al, 89.9% of support
group members reported that support group meetings helped
create a forum for sharing knowledge and experiences, some of
which related to taking medications. In Mozambique, PLHIV
enrolled in support groups reported increased adherence.23
Two studies described negative outcomes. In a South
Africa study, male participants in support groups felt under
pressure to conform to a lifestyle that was not consistent with
established gender roles,31 whereas a large mixed methods
study with participants from Burkina Faso, Kenya, Malawi,
and Uganda showed that membership in a support group was
associated with nondisclosure to partners.28 These issues will
need to be addressed to maximize the potential of support
groups as an intervention.
Limitations
Conclusions of this review should be interpreted with
caution given the methodological limitations and relatively
small number of studies. The majority of the studies were
observational, 8 used qualitative methods, 3 studies enrolled
less than 70 participants each,15,24,31 1 study included only
men,31 and 3 recruited only women.25,29,32 Therefore, the
ﬁndings may not be generalizable to the broader community
and to other patient populations. Additionally, PLHIV partici-
pating in support groups often received other interventions.
The impact of the other interventions or their combination may
have inﬂuenced the results reported in this review. Evidence
from this review may not be adequate to inform major policy
changes regarding the role of support groups.
Research Gaps
Although this review has provided useful information
regarding support groups, there are information gaps. Which
patients are most in need of support group participation?
What venues are optimal, and how do these depend on the
populations participating? Who should lead the support
groups? What speciﬁc considerations should be given to
newly diagnosed patients, men, women, key population
groups, and those starting ART?
Cost-effectiveness of the intervention is an outstanding
issue. None of the studies included costing data; nor were
they designed to test effectiveness for the outcomes under
review. The Mozambique CAG pilot was successful in part
because more than a quarter (28%) of the members shared the
cost of transport. It is unclear whether other types of support
groups would be feasible and sustainable in their respective
settings. Programs already underway such as the national
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rollout of CAGs in Mozambique should be rigorously
evaluated. Data from these evaluations could be useful for
national governments and donor funding decisions.
Programmatic Considerations
for Implementation
It is apparent from this review that support groups have
the potential to play an important role in HIV care and
treatment programs, in terms of having impact on key health
outcomes, and in retaining HIV-infected persons in care.
They may also provide an alternative care model toward
attaining universal access to ART in settings where long
distances to health facilities, shortage of human resources,
and waiting times remain barriers to HIV care. Implementa-
tion issues and challenges were beyond the scope of this
review; however, several merit discussion: membership and
access; resources and sustainability; monitoring and evalua-
tion; and models of implementation.
Regarding membership, not all patients need or want
to participate in support groups, and health care facilities
may not be able to accommodate all patients who might
beneﬁt from a support group intervention. Therefore, it is
important to target support group resources to those who
might beneﬁt the most. For example, support groups
targeting key populations could be useful in settings with
high levels of stigma and discrimination directed toward
PLHIV. In this review, most support groups were formed to
support patients on ART. Programs for pre-ART patients
should be developed to determine whether these patients
might beneﬁt from support group participation. Implement-
ers should identify motivators for attendance and also,
perhaps, criteria to determine when participation might no
longer be necessary. The needs for patients in urban vs. rural
HIV care programs may differ signiﬁcantly.
Second, resources are needed to start and maintain
support groups—both human and infrastructural. Support group
programs require physical meeting space away from crowded
health facilities; they may require phone credit, transportation
support, and refreshments during meetings, among other needs.
Training in facilitation skills and capacity building are espe-
cially important to foster free expression and to encourage full
participation. The actual costs associated with running support
groups are difﬁcult to estimate in part due to lack of accurate
data on the number of PLHIV who currently access services.
The comparative evaluation of different models would enrich
our knowledge of which support group models to scale up.
Programs should understand how best to make support groups
self-sustaining and less dependent on donor funding. Early
lessons from Mozambique suggest that the CASG support
group model is self-sustaining and could potentially be
replicated in other settings.
Third, for donors and ministries of health that fund
support groups, monitoring and evaluation metrics are
important to assess the value of support group interventions.
Community-level HIV indicators, including those that mea-
sure linkage between facilities and the community and
retention in support group programs will be important to
develop to monitor success and to ensure accountability.
Last, support groups are yet to be formalized as
standard practice in HIV care and treatment programs;
inadequate data as evident in this literature review are one
of the challenges. Models for such programing need to be
explored. For example, a model that links community-based
support groups to an assigned health facility in a hub-and-
spoke fashion with a formalized system for bidirectional
referral would be useful to explore.
CONCLUSIONS
Implementing support groups in PLHIV is likely to
have an impact on morbidity and retention in care and has
the potential to improve QOL and mortality. Additional
research and operational lessons are needed to maximize the
beneﬁts of support groups as an integral component of HIV
care and treatment.
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